Weimin Mao

Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial

Jianxing He, Chunxia Su, Wenhua Liang et al. · The Lancet Respiratory Medicine · 2021 · 178 citations

Medicine, Immunology, Pathology +8

A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma

Xiaoling Xu, YU Hui-qin, Wei Hu et al. · PLoS ONE · 2015 · 125 citations · Full text

The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer

Zhiwen Pan, Weimin Mao, Yejiang Bao et al. · Cancer Medicine · 2016 · 98 citations · Full text

Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes

Si‐Yang Liu, Hua Bao, Qun Wang et al. · Nature Communications · 2021 · 70 citations · Full text

Cell-Cycle and DNA-Damage Response Pathway Is Involved in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer

Yun Fan, Xuehua Zhu, Yan Xu et al. · Clinical Cancer Research · 2017 · 64 citations · Full text